Introduction
============

Cancer is largely incurable once tumor cells begin to metastasize and colonize in distant organs. Metastasis is initiated by tumor cells dislodging from the primary tumor and intravasating into the blood stream. This process is supported by a specific genetic program, epithelial-mesenchymal transition (EMT), which enables tumor cells to detach from the tumor tissue and invade the surrounding tumor stroma as a single cell [@B1]. Then, after entering the blood stream, tumor cells are carried into the vasculature of distant organs, where they extravasate or proliferate within the vasculature [@B2], [@B3]. This stage represents an important switch from tumor cell dissemination to metastatic colonization, which depends on cell-autonomous processes such as tumor initiation and mesenchymal-epithelial transition [@B4], [@B5]. Another important determinant for metastatic colonization is the nature of the tissue environment, which needs to provide critical survival and proliferative cues in order for tumor cell colonization to succeed [@B6]-[@B8]. Failure to provide these cues can either result in tumor cell death or dormancy.

The ability of tumor cells to generate colonies in distant organs depends in large parts on their capacity to proliferate. Starting out as a single cell, this process requires adhesive interactions of integrins with the extracellular matrix, which result in focal adhesion formation and subsequent activation of MAP kinases or PI3-kinase [@B4], [@B9]. In line with this, adhesive pathways that modulate F-actin and stress fiber assembly are often up-regulated in metastatic tumor cells and their inhibition has been shown to be anti-metastatic [@B2], [@B7]. The capacity to generate productive adhesive interactions is also determined by the properties of the surrounding extracellular matrix [@B6], [@B10]. To this end, it has been demonstrated that fibrin is significantly more efficient in supporting colony formation than collagen I [@B6]. This effect is highly relevant *in vivo* as embedding in a 3-dimensional (3D) matrix of fibrin specifically conveys tumor- and metastasis-initiating capabilities while treatment with clotting inhibitors or knocking down fibrin(ogen) severely impairs the capacity of tumor cells to metastasize [@B6], [@B11], [@B12].

We previously showed that blood clotting specifically supports lung metastasis but not metastasis to the liver [@B13]. Conversely, we found that tumor cells from cancers that predominantly metastasize to the lung, such as renal cell carcinoma (RCC) and soft tissue sarcoma (STS), display a specific fibrin-invasive phenotype [@B10]. Invadopodia formation in these tumor types depends on a constitutively active form of integrin αvβ3, which promotes fibronectin matrix formation in fibrin-embedded tumor cells. Fibronectin in turn has been shown to activate dormant tumor cells and to induce tumor cell metastasis [@B7]. In line with this, it has been shown that high levels of fibronectin correlate positively with poor outcome in patients with RCC and other malignancies [@B14], [@B15]. Based on the apparent role of clotting in tumor metastasis, we aimed to define the function of fibronectin matrix formation for kidney tumor cell colonization in fibrin.

Materials and Methods
=====================

**Tumor Cells.**RCC4, 786-0 (renal cell carcinoma, RCC) and HT1080 cells (soft tissue sarcoma, STS) were purchased from ATCC and cultured per manufacturer\'s specifications. Primary human tumor cells were isolated from kidney tumors of 2 patients with metastatic RCC (pT3bN0M1, pT3bN2Mx) and 2 patients with localized RCC (ea. pT1aNxMx) as previously described [@B10].

**Cell Invasion, Colony Formation and Western Blot**. Tumor cells embedded in various 3D matrices were analyzed for invadopodia and colony formation using phase contrast or confocal microscopy as previously described [@B10], [@B13], [@B16], [@B17]. Western blot analysis was performed as previously described [@B10], [@B17]. Y-27632 Rho kinase inhibitor (EMD Millipore) or recombinant human HGF (R&D Systems) were added to cultures where indicated.

**Experimental Metastasis.**Lungs from female, 6-8 weeks old athymic nude mice (Charles Rivers) were isolated 6 weeks after intravenous injection (tail vein) with 2.5x10^5^ 786-0 kidney cancer cells in the presence or absence of 500 IU hirudin (EMD Millipore). Lungs were subsequently fixed in Bouin\'s solution and analyzed for tumor multiplicity as well as tumor size using a stereo microscope (Zeiss Stemi 2000-C).

**shRNA Mediated Gene Silencing.** To achieve stable knockdown of fibronectin, we transduced HT1080 cells with lentiviral shRNA vectors compared to a scrambled control shRNA (University of Pittsburgh Cancer Institute Vector Core Facility) as previously described [@B10]. Target knockdown was confirmed by western blot analysis.

**Statistical Analysis.**Data were analyzed using unpaired two-tailed Student\'s *t* test or one-way ANOVA followed by the posthoc Tukey\'s multiple comparisons test (GraphPad Prism 5). Treatment differences with a two-sided p value \< 0.05 were considered significantly different. Error bars show mean ± SEM.

Results
=======

*Metastatic kidney tumor cells colonize fibrin.*Fibrin matrices have been shown to promote the tumorigenic potential in several tumor types [@B6]. To determine the role of fibrin for tumor cell proliferation in kidney cancer, we embedded primary tumor cells from patients with clear cell RCC in fibrin and scored the clots for tumor colonization over time. Surrounded by 3D fibrin, tumor cells from metastatic RCC began to proliferate soon after embedding with a doubling in cell number after 24 hours and a tripling after 48 hours (Fig. [1](#F1){ref-type="fig"}A). Cells from non-metastatic tumors on the other hand did not grow at all in fibrin but rather slightly declined in numbers, demonstrating that the clotting cascade specifically promotes colony formation in an aggressive, metastatic subset of kidney tumors. To determine if clotting is also pro-metastatic *in vivo*, we injected 786-0 kidney tumor cells into the tail vein of athymic nude mice in the presence of the thrombin inhibitor hirudin. Notably, a single application of anticoagulant significantly reduced the overall appearance of metastatic kidney tumors in the lung over time (Fig. [1](#F1){ref-type="fig"}B). In addition, we found that lung tumors had a significantly smaller diameter after co-injection with hirudin indicating that inhibiting clot formation at the time of tumor cell seeding in the lung is associated with reduced tumor formation as well as growth (Fig. [1](#F1){ref-type="fig"}C). Moreover, the *in vivo* results are in line with our data that fibrin promotes colony formation of primary tumor cells from patients with metastatic RCC *in vitro*.

*Fibronectin promotes colony formation of tumor cells in fibrin.* To determine if the capacity of tumor cells to colonize in 3D culture depends on specific extracellular matrix properties, we embedded a panel of tumor cells side by side in fibrin versus matrigel. While 786-0, RCC4 and HT1080 tumor cells replicated the previously observed colony formation of clinical RCC cells in fibrin, cell numbers remained largely unchanged after embedding the same cell lines in matrigel (Fig. [2](#F2){ref-type="fig"}A). Paralleling this result, we made the observation that fibrin-embedded tumor cells generated an extensive fibronectin matrix, which was necessary to support tumor cell spreading as well as proliferation in fibrin (Fig. [2](#F2){ref-type="fig"}B-D; [Supplementary Material](#SM1){ref-type="supplementary-material"}: Fig. S1). Matrigel-embedded tumor cells, in contrast, displayed a round morphology and an apparent lack of fibronectin matrix deposition unless cells were treated with hepatocyte growth factor, a cytokine that has been shown to induce kidney tumor cell sprouting (Fig. [2](#F2){ref-type="fig"}C-D) [@B18]. Interestingly, tumor cell growth in fibrin was impaired whether we embedded fibronectin shRNA-transformed tumor cells in fibrin or in fibrin-fibronectin suggesting that tumor cell sprouting depended on endogenous fibronectin (Fig. [2](#F2){ref-type="fig"}B). Together, these results suggest a close connection between fibronectin expression, tumor cell spreading and colony formation in fibrin compared to other extracellular matrices such as matrigel.

*Tumor cell colonization and fibronectin assembly in 3D fibrin depends on actomyosin dynamics.* We previously demonstrated that fibronectin is necessary for stress fiber formation in fibrin [@B10]. To further evaluate the role of stress fiber formation in fibrin-embedded tumor cells, we stained 786-0 cells cultured for 48 hours in 3D fibrin with an antibody for phosphorylated myosin light chain (pMLC). Subsequent analysis with confocal microscopy documented that spread 786-0 cells expressed high levels of pMLC, which co-localized completely with F-actin in stress fibers (Fig. [3](#F3){ref-type="fig"}A). To determine the functional implications of stress fiber formation, we treated fibrin-embedded 786-0 cells with the Rho kinase inhibitor Y-27632, which inhibits stress fiber formation through dephosphorylation of MLC. As a consequence, fibronectin matrix assembly and colony formation were significantly impaired in Y-27632-treated cells (Fig. [3](#F3){ref-type="fig"}B-C). Moreover, the inability of cells to generate stress fibers correlated with a significant reduction in expression of Slug (snail2), a transcription factor involved in tumor initiation as well as epithelial-mesenchymal transition (EMT) (Fig [3](#F3){ref-type="fig"}D). Together, these results indicate that tumor cell spreading depends on Rho kinase activity, which in turn generates important signals for tumor colonization in 3D fibrin.

*Stress fiber formation is a specific feature of metastatic RCC.* Primary kidney cancer cells have been shown to generate an elaborate fibronectin matrix if they are derived from patients with metastasis, while non-metastatic RCC cells are largely devoid of a fibronectin matrix [@B10]. To determine if fibronectin matrix assembly correlates with stress fiber formation in clinical cancer, we embedded primary tumor cells from RCC patients with or without metastasis in fibrin and stained with an antibody against phosphorylated myosin light chain (pMLC) as well as phalloidin to visualize F-actin. Subsequent confocal microscopy revealed co-localization of pMLC as well as F-actin in extensive stress fibers in metastatic RCC cells (Fig. [4](#F4){ref-type="fig"}A). In non-metastatic cells, pMLC staining was significantly weaker while F-actin was diffusely distributed throughout the cell (Fig. [4](#F4){ref-type="fig"}A-B). Together, these results show that stress fiber formation in fibrin is a specific function of metastatic RCC cells embedded in fibrin. Moreover the results indicate a link between cell spreading and colony formation in fibrin that correlates with kidney cancer metastasis.

Discussion
==========

Blood clotting and subsequent fibrin formation are important factors for tumor cell seeding to the lungs [@B11]. The objective of this study was to determine the role of fibrin formation for kidney cancer metastasis in comparison to other 3-D matrices such as Matrigel™, an ECM mixture consisting of the basement membrane components collagen IV, laminin and fibulin. Here, we show that fibrin supports colonization of metastatic kidney tumor cells in an animal model *in vivo* as well as in 3D culture *in vitro*. Colony formation was more efficient in 3D fibrin than in matrigel and depended on the ability of metastatic cells to generate a fibronectin matrix as a prerequisite for subsequent spreading. Together our results show that fibrin promotes fibronectin matrix formation and kidney tumor cell spreading. Moreover, they suggest that these functions are important for the initiation of lung metastasis in renal cell carcinoma.

The role of the clotting system for tumor metastasis has long been established [@B12], [@B19]. To this end, it has been demonstrated that tumor cell seeding is strongly reduced in transgenic mice deficient for platelet activators, fibrinogen or other coagulation factors [@B20], [@B21]. More recently, it has been shown that blood clotting is specifically important for metastasis to the lung, which features blood vessels with a tight layer of endothelium and a continuous basement membrane [@B10], [@B22], [@B23]. As a result of these distinct vascular features, tumor cell extravasation is much more elaborate in the lung vasculature than in the liver vasculature, which lacks a basement membrane underneath a fenestrated endothelium [@B24]. In this situation, adhesive interactions with a provisional matrix of platelets and fibrin can provide critical cues for tumor cell survival and invasion in the lung vasculature [@B10]. Consequently, fibrin formation plays a major role in promoting metastatic pathways in malignancies that predominantly metastasize to the lung such as renal cell carcinoma and soft tissue sarcoma [@B10].

The function of the clotting cascade is to protect tumor cells from the cytotoxic effects of circulating natural killer cells [@B19], [@B21]. In addition, it has been shown that components of the clotting system support tumor cell extravasation by promoting epithelial to mesenchymal transition as well as the retraction of endothelial cells [@B3], [@B10], [@B25]. Extravasation also requires tumor cells to penetrate the basement membrane of the pulmonary vasculature, which depends on a specific set of properties including the auto- or paracrine expression of HGF to promote c-met-dependent invasion and subsequent tumor cell sprouting [@B18]. Alternatively, tumor cells can survive and proliferate in the lumen of pulmonary blood vessels [@B2]. Such a mechanism for metastatic outgrowth is supported by our data showing that clotting promotes colony formation of primary metastatic kidney tumor cells *in vitro* and metastatic outgrowth in a model of experimental metastasis*in vivo*. This is also in line with a recent report demonstrating that fibrin promotes stem cell-like properties in tumor cells [@B6].

We and others have shown that colonization of fibrin with tumor cells depends on integrin αvβ3, which in its activated form participates in the generation of a fibronectin matrix [@B6], [@B10]. This is significant as we previously demonstrated that spreading and fibronectin matrix formation in 3D fibrin is a prerequisite of metastatic RCC cells [@B10]. Mechanistically, integrin αvβ3 and fibronectin promote the expression of the EMT master regulator Slug, which also has been shown to promote tumor initiation [@B10], [@B26]. Here we show that Slug was reduced in kidney cancer cells when we inhibited stress fiber formation with the Rho kinase inhibitor Y-27632 suggesting that the tensile strength generated through cell matrix interaction is relevant for the up-regulation of a critical pro-metastatic transcription factor. This function correlates directly with fibronectin expression because in absence of fibronectin, fibrin or matrigel alone were unable to provide the tensile strength necessary to promote stress fiber formation in tumor cells. Interestingly, while both spreading and colony formation depended on the expression of tumor cell fibronectin, this function was not rescued by the addition of plasma fibronectin to fibrin. This difference in function could be owed to the specific expression of alternatively spliced modules in cellular fibronectin [@B27]. Alternatively, it is conceivable that the formation of compact fibrin fibrils is impaired as free diffusion of plasma fibronectin is hindered following the FXIII-mediated cross-linking activity of fibronectin to fibrin [@B28].

Overall, our data suggest that fibronectin matrix formation is a prerequisite for tumor cell spreading and colonization in 3D. In agreement with this, it has been shown that 786-0 kidney cancer cells are unable to assemble fibronectin fibers when cultured on 2D plastic even though they generate an elaborate fibronectin matrix in 3D fibrin as well as matrigel [@B29]. Lack of fibronectin matrix assembly in 2D has been attributed to the loss of functional von-Hippel-Lindau Protein (VHL), which supports fibronectin fibril formation through a distinct mechanism involving β1 integrin in combination with RhoA [@B29]-[@B31]. However, while these VHL-related functions induce spreading and extracellular matrix formation in 2D, they are largely insufficient for mediating spreading of VHL-positive kidney tumor cells in 3D matrigel [@B18]. VHL-negative 786-0 cells on the other hand spread in matrigel, albeit to a lesser extent than in fibrin, and this function correlates with fibronectin matrix assembly. Interestingly, kidney tumor cell spreading and fibronectin matrix formation in matrigel can be induced through stimulation of the receptor tyrosine kinase c-met, which has been shown to promote cell scattering through cross-talk with β1 integrin [@B32]. A similar mechanism involving crosstalk between β3 integrin and other receptor tyrosine kinases activated in RCC such as PDGFR or EGFR could account for spreading and subsequent fibronectin assembly in 3D fibrin [@B33], [@B34].

In addition to fibronectin matrix formation, we found that kidney tumor cells generated extensive stress fibers following embedding in fibrin. Both stress fiber and fibronectin matrix formation have been shown to be relevant for the metastatic outgrowth of dormant breast tumor cells [@B7]. This process appears to be highly relevant because primary tumor cells from patients with kidney cancer metastasis where significantly more prone to stress fiber formation than cells from patients where the tumor was limited to the kidney. Moreover, inhibition of actomyosin contraction with the Rho kinase inhibitor Y-27632 inhibited fibronectin matrix assembly as well as colony formation in fibrin-embedded tumor cells. While the mechanism of fibronectin and stress fiber formation is relevant for tumor cell colonization, it does not appear to play a role in kidney tumor cell survival [@B17]. Based on these results, we propose a mechanism where fibrin promotes adhesive interactions that result in fibronectin matrix and stress fiber assembly. This in turn appears to be a prerequisite for expression of the EMT master regulator and cancer stem cell factor Slug/Snail (Fig. [5](#F5){ref-type="fig"}) [@B26], [@B35]. Therefore, inhibiting actomyosin dynamics in kidney cancer could be an attractive strategy to prevent and treat metastasis.

Supplementary Material
======================
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**Fig. S1** *Knockdown of fibronectin*, western blotting for fibronectin (FN) to demonstrate knockdown in shFN HT1080 clone compared to shSCR control. Β-Actin shows protein loading.
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Click here for additional data file.
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![*Metastatic kidney tumor cells colonize fibrin.*(A), colony formation of fibrin-embedded primary RCC cells from patients with or without metastasis after 2, 24, and 48 hours. Diagram shows average number of tumor cells per optical field. \* p \< 0.05, \*\*\* p \< 0.001, compared to 2 hours. \* p \< 0.05, 24 hours compared to 48 hours. (B-C), the number of tumor nodules on the surface of lungs (B; tumor multiplicity) and the average diameter of lung tumors (C; tumor size) was assessed on lungs isolated six weeks after i.v. injection of 5 x 10^5^ 786-0 RCC cells in the presence of 500 IU hirudin (Hir) or vehicle (Veh), \* p \< 0.05.](jcav06p0098g001){#F1}

![*Fibrin promotes fibronectin matrix deposition.*(A), 786-0, RCC4 and HT1080 cells embedded in fibrin and matrigel were analyzed for colony formation after 48 hours as fold change over 24 hours (dotted line). (B), fibrin (Fib)- and fibrin-fibronectin (FibFN)-embedded HT1080 cells transformed with fibronectin (shFN) or scrambled (shSCR) shRNA were analyzed for invadopodia (Inv; 24 hours) and colony formation (Col; 48 hours). Fib control was set to 100%. \*\*\*P \< 0.001, \*\*P \< 0.01, shSCR versus shFN. (C), tumor cells embedded in fibrin, matrigel (Mat) or matrigel + 166.7 ng/ml HGF (Mat+HGF) were scored for invadopodia (invad+) or fibronectin matrix formation (FN+) as percent of total tumor cell count per optical field using phase contrast or confocal microscopy, respectively. \*\*\*P \< 0.001, Fib vs. Mat+HGF and Mat, \*\*P \< 0.01, Mat+HGF vs. Mat. (D), confocal images of 786-0 cells 48 hours after embedding in fibrin (top), matrigel (middle), or matrigel + 166.7 ng/ml HGF (bottom) were stained for fibronectin (green). Nuclei are stained with draq5 (blue). Scale bar, 20 µm.](jcav06p0098g002){#F2}

![*Tumor cell colonization of fibrin depends on stress fiber formation.*(A), fibrin-embedded 786-0 cells were fixed after 48 hours and probed for phospho-myosin light chain (pMLC; green) as well as F-actin (red) using confocal microscopy. Nuclei are stained with draq5 (blue). (B), confocal microscopy images of 786-0 cells treated with Y-27632 (right) or vehicle (left) for 24 hours and then fixed and stained with anti-fibronectin (green) as well as phalloidin (red). Scale bar, 20 µm. (C), 786-0 cells treated with 25 µM Y-27632 or vehicle were analyzed for colony formation 48 hours after embedding in fibrin using phase contrast microscopy. \*P \< 0.05. (D), 786-0 cells were probed for Slug after treatment with Y-27632 for 24 hours.](jcav06p0098g003){#F3}

![*Increased actomyosin dynamics in metastatic RCC.*(A), primary RCC cells from patients with or without metastasis were fixed after 48 hours of embedding in fibrin and probed for phospho-myosin light chain (pMLC; green) and F-actin (red) using confocal microscopy. Scale bar, 20 µm. (B), microscopy fields were scored for stress fiber (SF)- and pMLC-positive RCC cells (M, metastastatic; NM, non-metastatic; 2 patients ea.) as percent of total after 48 hours embedding in fibrin. \*\*\*P \< 0.001, M1 and 2 vs. NM1 and 2.](jcav06p0098g004){#F4}

![Diagram depicting the interaction of metastatic RCC with fibrin.](jcav06p0098g005){#F5}
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